Midazolam for Back Pain: When Data Are Not Proof
by Zangani • 10 November 2011 • Pain News
Here is a lesson in evidence-based pain management. Researchers reported that intrathecal midazolam, a benzodiazepine, was a beneficial supplement to standard analgesic therapy for recalcitrant lower-back pain. However, because of the study design and limited data this is not valid evidence of treatment effects, which raises questions about why this study was published. Writing in the journal